vs

Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Commercial Vehicle Group, Inc. is the larger business by last-quarter revenue ($154.8M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -5.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -10.8%).

WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CVGI vs PRCT — Head-to-Head

Bigger by revenue
CVGI
CVGI
1.9× larger
CVGI
$154.8M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+25.4% gap
PRCT
20.2%
-5.2%
CVGI
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-10.8%
CVGI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVGI
CVGI
PRCT
PRCT
Revenue
$154.8M
$83.1M
Net Profit
$-31.6M
Gross Margin
9.7%
64.9%
Operating Margin
-1.2%
-4.1%
Net Margin
-38.1%
Revenue YoY
-5.2%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVGI
CVGI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$154.8M
$76.4M
Q3 25
$152.5M
$83.3M
Q2 25
$172.0M
$79.2M
Q1 25
$169.8M
$69.2M
Q4 24
$163.3M
$68.2M
Q3 24
$171.8M
$58.4M
Q2 24
$193.7M
$53.4M
Net Profit
CVGI
CVGI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-7.1M
$-21.4M
Q2 25
$-4.8M
$-19.6M
Q1 25
$-4.3M
$-24.7M
Q4 24
$-18.9M
Q3 24
$9.5M
$-21.0M
Q2 24
$-1.6M
$-25.6M
Gross Margin
CVGI
CVGI
PRCT
PRCT
Q1 26
64.9%
Q4 25
9.7%
60.6%
Q3 25
10.5%
64.8%
Q2 25
11.4%
65.4%
Q1 25
10.5%
63.9%
Q4 24
8.0%
64.0%
Q3 24
9.6%
63.2%
Q2 24
10.6%
59.0%
Operating Margin
CVGI
CVGI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-1.2%
-40.6%
Q3 25
-0.7%
-27.8%
Q2 25
0.5%
-28.0%
Q1 25
0.8%
-39.7%
Q4 24
-3.2%
-28.9%
Q3 24
-0.6%
-38.4%
Q2 24
0.5%
-50.3%
Net Margin
CVGI
CVGI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-4.6%
-25.7%
Q2 25
-2.8%
-24.7%
Q1 25
-2.5%
-35.8%
Q4 24
-27.6%
Q3 24
5.5%
-35.9%
Q2 24
-0.8%
-48.0%
EPS (diluted)
CVGI
CVGI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.05
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVGI
CVGI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$104.9M
$51.7M
Stockholders' EquityBook value
$133.4M
$347.7M
Total Assets
$391.7M
$487.1M
Debt / EquityLower = less leverage
0.79×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVGI
CVGI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
CVGI
CVGI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$104.9M
$51.6M
Q3 25
$108.2M
$51.6M
Q2 25
$118.2M
$51.5M
Q1 25
$117.4M
$51.5M
Q4 24
$135.5M
$51.5M
Q3 24
$128.8M
$51.4M
Q2 24
$142.0M
$51.4M
Stockholders' Equity
CVGI
CVGI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$133.4M
$365.9M
Q3 25
$136.5M
$380.3M
Q2 25
$142.6M
$385.8M
Q1 25
$136.7M
$389.2M
Q4 24
$135.6M
$402.2M
Q3 24
$179.3M
$241.2M
Q2 24
$169.6M
$251.8M
Total Assets
CVGI
CVGI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$391.7M
$508.1M
Q3 25
$400.3M
$511.5M
Q2 25
$429.8M
$513.1M
Q1 25
$419.8M
$519.4M
Q4 24
$424.6M
$534.0M
Q3 24
$495.3M
$374.1M
Q2 24
$503.2M
$374.4M
Debt / Equity
CVGI
CVGI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.79×
0.14×
Q3 25
0.79×
0.14×
Q2 25
0.83×
0.13×
Q1 25
0.86×
0.13×
Q4 24
1.00×
0.13×
Q3 24
0.72×
0.21×
Q2 24
0.84×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVGI
CVGI
PRCT
PRCT
Operating Cash FlowLast quarter
$12.3M
Free Cash FlowOCF − Capex
$8.7M
FCF MarginFCF / Revenue
5.6%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$34.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVGI
CVGI
PRCT
PRCT
Q1 26
Q4 25
$12.3M
$-10.3M
Q3 25
$-1.7M
$-6.6M
Q2 25
$18.9M
$-15.0M
Q1 25
$15.2M
$-17.0M
Q4 24
$-26.6M
$-32.4M
Q3 24
$-17.1M
$-18.8M
Q2 24
$12.6M
$-15.7M
Free Cash Flow
CVGI
CVGI
PRCT
PRCT
Q1 26
Q4 25
$8.7M
$-12.2M
Q3 25
$-3.5M
$-9.5M
Q2 25
$17.4M
$-17.8M
Q1 25
$11.4M
$-18.8M
Q4 24
$-30.6M
$-33.6M
Q3 24
$-20.3M
$-19.0M
Q2 24
$6.4M
$-16.8M
FCF Margin
CVGI
CVGI
PRCT
PRCT
Q1 26
Q4 25
5.6%
-15.9%
Q3 25
-2.3%
-11.4%
Q2 25
10.1%
-22.5%
Q1 25
6.7%
-27.2%
Q4 24
-18.7%
-49.2%
Q3 24
-11.8%
-32.6%
Q2 24
3.3%
-31.4%
Capex Intensity
CVGI
CVGI
PRCT
PRCT
Q1 26
Q4 25
2.3%
2.4%
Q3 25
1.2%
3.4%
Q2 25
0.9%
3.5%
Q1 25
2.2%
2.7%
Q4 24
2.4%
1.7%
Q3 24
1.9%
0.4%
Q2 24
3.2%
2.0%
Cash Conversion
CVGI
CVGI
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-1.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVGI
CVGI

Global Seating$70.7M46%
Global Electrical Systems$49.7M32%
Trim Systems And Components$34.4M22%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons